Oncolytic Virus (Delytact/G47-delta)

Type: biologic

Status: Japan: Approved (Sakigake). FDA: Fast Track.

Developer: Daiichi Sankyo

Breakthrough Summary

No summary available.

Mechanism of Action

Engineered herpes virus that selectively infects and destroys glioblastoma cells

Year: 2021